Clinical Trials Logo
  1. Home
  2. Uterine Atony
  3. NCT01630187

Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section

Uterine Atony Clinical Trial

Official title:
Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony During Elective Cesarean Section: a Randomized Controlled Trial

Clinical Trial Summary

The purpose of this study is to evaluate the effectiveness of two doses of carbetocin (50 mcg vs 100 mcg) in preventing uterine atony during elective cesarean section.

Clinical Trial Description

Postpartum hemorrhage is a major cause of mortality and morbidity in the world, and it is most often caused by uterine atony. To prevent this complication, uterotonic medication is used during elective cesarean section.

Carbetocin, a long-acting synthetic analogue of oxytocin, has been used for this purpose for many years. This medication has numerous side effects: hypotension, tachycardia, nausea, vomiting, chest pain, etc. Using a smaller dose of carbetocin might lower the incidence of these side effects, without compromising prevention of uterine atony in a low-risk group of patient. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01630187
Study type Interventional
Source Laval University
Contact
Status Completed
Phase Phase 4
Start date April 2012
Completion date July 2012
View Details
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02910115 - Cooling the Uterus in C-section After Dysfunctional Labor N/A
Withdrawn NCT02410655 - An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery Phase 4
Completed NCT00790062 - Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT Phase 4
Recruiting NCT01579201 - ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery Phase 4
Completed NCT03867383 - Calcium Chloride for Prevention of Uterine Atony During Cesarean Phase 1/Phase 2
Active, not recruiting NCT03584854 - Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial Phase 4
Completed NCT02780245 - Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section Phase 4
Completed NCT00785395 - Up-Down Oxytocin Infusion Phase 4
Withdrawn NCT03303235 - Intravenous Versus Intramuscular Administration of Methylergonovine for Uterine Contraction in Cesarean Sections Early Phase 1
Completed NCT02229513 - Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage N/A
Not yet recruiting NCT06192836 - Placental Removal Method And Uterine Massage On Preventing Postpartum Hemorrhage
Recruiting NCT03413917 - Exploration and Determination of Genomic Markers Predictive of Uterine Atony
Withdrawn NCT01252342 - Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery? Phase 4
Completed NCT04690153 - Novel Approach of Hayman Uterine Compression Sutures for Management of Severe Atonic Postpartum Hemorrhage: Three Vertical Sutures
Completed NCT05027048 - Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery Phase 3
Completed NCT01549223 - Oxytocin And Uterotonic Agent Use For Cesarean Delivery Phase 4